Open Menu
About
back
About
News
Event Calendar
Contacts
Tech Licensing
back
Tech Licensing
Innovators
back
Innovators
Report a New Innovation
Disclose Biological Materials
Innovators’ Guide
FAQ & Resources
Market Your Tech
Startups
Industry
Fellows Program
Ventures
The Hub
back
The Hub
Advisors
Apply
Client Resources
Companies
The Collaboratory for Women Innovators
back
The Collaboratory for Women Innovators
Programs
Contact
Donate
Sid Martin Bio
back
Sid Martin Bio
Why Us
Companies
Client Resources
Community
Apply
UF Research
About
News
Event Calendar
Contacts
Tech Licensing
Innovators
Report a New Innovation
Disclose Biological Materials
Innovators’ Guide
FAQ & Resources
Market Your Tech
Startups
Industry
Fellows Program
Ventures
The Hub
Advisors
Apply
Client Resources
Companies
The Collaboratory for Women Innovators
Programs
Contact
Donate
Sid Martin Bio
Why Us
Companies
Client Resources
Community
Apply
UF Research
← Back to All Technologies
Category:
Technology Classifications > Research Tools > Biological Materials
Technology Classifications > Research Tools > Others
Bookmark this page
Download as PDF
For more information, complete the form below. We'll respond via email.
Inventors:
Martha Campbell Thompson
Monoclonal Antibody Against Cholecystokinin (CCK) Receptor 2
Case ID:
MP11934_1
Web Published:
5/14/2019
Targeting Proteins that Regulate Anxiety and Digestion
Scientists at the University of Florida have developed a wide variety of monoclonal and polyclonal antibodies, cell lines, vectors and biological materials that can be used in other research projects. Anyone interested in accessing these materials via a license from the University of Florida should contact our office to make arrangements.This antibody was generated against recombinant rat CCKB receptor. The antibody cross-reacts with mouse CCK2 as well as the human homolog (92% amino acid similarity) and has been used to show positive immuno-reactivity to cortical neurons via immunohistochemistry. CCK2 is a receptor that helps regulate anxiety, digestion, and locomotion. This antibody is expected to be useful for studies in the central nervous system, gastrointestinal tract and other organs.
Patent Information:
App Type:
Patent No.:
Patent Status:
Direct Link:
https://ufinnovate.technologypublisher.com/tech/Monoclonal_Antibody_Against_Cholecystokinin_(CCK)_Receptor_2
Case ID:
MP11934_1